EMERALD THERAPEUTICS Trademark

Trademark Overview

On Monday, October 11, 2021, a trademark application was filed for EMERALD THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EMERALD THERAPEUTICS trademark a serial number of 97068643. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, October 3, 2024. This trademark is owned by Emerald Therapeutics, Inc.. The EMERALD THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used to treat viral infections; pharmaceutical preparations, namely, nucleic acids for therapeutic use; pharmaceutical preparations used to detect and regulate target polynucleotides
emerald therapeutics

General Information

Serial Number97068643
Word MarkEMERALD THERAPEUTICS
Filing DateMonday, October 11, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, October 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 23, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations used to treat viral infections; pharmaceutical preparations, namely, nucleic acids for therapeutic use; pharmaceutical preparations used to detect and regulate target polynucleotides
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmerald Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameEmerald Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 14, 2021NEW APPLICATION ENTERED
Tuesday, November 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ASSIGNED TO EXAMINER
Thursday, July 14, 2022NON-FINAL ACTION WRITTEN
Thursday, July 14, 2022NON-FINAL ACTION E-MAILED
Friday, July 15, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, July 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 15, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, July 15, 2022EXAMINERS AMENDMENT E-MAILED
Friday, July 15, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 3, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 23, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 23, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 17, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 17, 2023SOU EXTENSION 1 FILED
Monday, April 17, 2023SOU EXTENSION 1 GRANTED
Wednesday, April 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 4, 2023SOU EXTENSION 2 FILED
Wednesday, October 4, 2023SOU EXTENSION 2 GRANTED
Friday, October 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 18, 2024SOU EXTENSION 3 FILED
Thursday, April 18, 2024SOU EXTENSION 3 GRANTED
Thursday, October 3, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 3, 2024SOU EXTENSION 4 GRANTED
Thursday, October 3, 2024SOU EXTENSION 4 FILED
Friday, April 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

therapeutics emerald preparations pharmaceutical used regulate detect polynucleotides therapeutic target namely treat